
China has four locally developed COVID-19 vaccines approved for public use and pledged earlier to supply 10 million doses to COVAX without specifying the time frame of delivery. CanSinoBIO, Sinovac Biotech Ltd and China National Pharmaceutical Group Co Ltd (Sinopharm) have applied to join the initiative.
from International-News-Economic Times https://ift.tt/3rmyr4L
via
IFTTT
0 comments:
Post a Comment